Journal profile · Immunology
Archivum Immunologiae et Therapiae Experimentalis
ISSN 0004-069X · eISSN 1661-4917 · Springer International Publishing · POLAND · Bimonthly · Founded 2006
Archivum Immunologiae et Therapiae Experimentalis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.19; hybrid open access; APC about USD 3,990; median 84 days to acceptance (48 articles, last 24 months); community-reported acceptance: fairly easy; 31 articles in 2025; indexed in SCIE and Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: Archivum Immunologiae et Therapiae Experimentalis is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website ·
Scope
Aims, scope and focus
Archivum Immunologiae et Therapiae Experimentalis is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 37.2% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Please Note: Archivum Immunologiae et Therapiae Experimentalis will be published by De Gruyter Poland as of 2024. For more information, see here. Archivum ...
From the journal's Aims & Scope
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology14.6%
- T-cell and B-cell ImmunologyImmunology and Microbiology12.2%
- Immunotherapy and Immune ResponsesImmunology and Microbiology10.3%
- Immune Response and InflammationImmunology and Microbiology7.9%
- Reproductive System and PregnancyImmunology and Microbiology3.9%
- Asthma and respiratory diseasesMedicine3.8%
- Immune cells in cancerImmunology and Microbiology3.5%
- Systemic Lupus Erythematosus ResearchMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.19LetPub ·
- CiteScore 2026-06
- 6LetPub ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 51LetPub ·
- h-index
- 84OpenAlex ·
- i10-index
- 596OpenAlex ·
- 2-year mean citedness
- 7OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 87.32%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 949 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 17 | 17 | 4 |
| 2025 | 31 | 31 | 58 |
| 2024 | 25 | 24 | 449 |
| 2023 | 23 | 15 | 321 |
| 2022 | 27 | 21 | 324 |
| 2021 | 36 | 28 | 658 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
84 daysMedian, submission to acceptance · P25–P75 65 days – 109 days
- Acceptance to online
- median 64 days (48 articles)
- Submission to online
- median 159 days
- Sample
- 48 articles with submission and acceptance dates (52 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,990 / EUR 3,190 / GBP 2,690 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- POLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2006
- ISSN
- 0004-069X
- Electronic ISSN
- 1661-4917
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Archivum Immunologiae et Therapiae Experimentalis
What CAS zone is Archivum Immunologiae et Therapiae Experimentalis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Archivum Immunologiae et Therapiae Experimentalis is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Archivum Immunologiae et Therapiae Experimentalis?
The latest impact factor listed by LetPub is 3.19; CiteScore 6, h-index 84.
How long does peer review take at Archivum Immunologiae et Therapiae Experimentalis?
Based on the dates recorded on 48 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 84 days (interquartile range 65–109 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Archivum Immunologiae et Therapiae Experimentalis?
According to LetPub and DOAJ records, Archivum Immunologiae et Therapiae Experimentalis is indexed in SCIE and Scopus.
Is Archivum Immunologiae et Therapiae Experimentalis open access, and what is the APC?
Archivum Immunologiae et Therapiae Experimentalis is a hybrid journal. For open-access publication: APC about USD 3,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .